General Information of Target

Target ID LDTP06463
Target Name Mitogen-activated protein kinase 11 (MAPK11)
Gene Name MAPK11
Gene ID 5600
Synonyms
PRKM11; SAPK2; SAPK2B; Mitogen-activated protein kinase 11; MAP kinase 11; MAPK 11; EC 2.7.11.24; Mitogen-activated protein kinase p38 beta; MAP kinase p38 beta; p38b; Stress-activated protein kinase 2b; SAPK2b; p38-2
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MSGPRAGFYRQELNKTVWEVPQRLQGLRPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQ
SLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQ
ALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMT
GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVG
TPSPEVLAKISSEHARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAA
EALAHAYFSQYHDPEDEPEAEPYDESVEAKERTLEEWKELTYQEVLSFKPPEPPKPPGSL
EIEQ
Target Type
Clinical trial
Target Bioclass
Enzyme
Family
Protein kinase superfamily, CMGC Ser/Thr protein kinase family, MAP kinase subfamily
Subcellular location
Cytoplasm
Function
Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway. MAPK11 is one of the four p38 MAPKs which play an important role in the cascades of cellular responses evoked by extracellular stimuli such as pro-inflammatory cytokines or physical stress leading to direct activation of transcription factors. Accordingly, p38 MAPKs phosphorylate a broad range of proteins and it has been estimated that they may have approximately 200 to 300 substrates each. MAPK11 functions are mostly redundant with those of MAPK14. Some of the targets are downstream kinases which are activated through phosphorylation and further phosphorylate additional targets. RPS6KA5/MSK1 and RPS6KA4/MSK2 can directly phosphorylate and activate transcription factors such as CREB1, ATF1, the NF-kappa-B isoform RELA/NFKB3, STAT1 and STAT3, but can also phosphorylate histone H3 and the nucleosomal protein HMGN1. RPS6KA5/MSK1 and RPS6KA4/MSK2 play important roles in the rapid induction of immediate-early genes in response to stress or mitogenic stimuli, either by inducing chromatin remodeling or by recruiting the transcription machinery. On the other hand, two other kinase targets, MAPKAPK2/MK2 and MAPKAPK3/MK3, participate in the control of gene expression mostly at the post-transcriptional level, by phosphorylating ZFP36 (tristetraprolin) and ELAVL1, and by regulating EEF2K, which is important for the elongation of mRNA during translation. MKNK1/MNK1 and MKNK2/MNK2, two other kinases activated by p38 MAPKs, regulate protein synthesis by phosphorylating the initiation factor EIF4E2. In the cytoplasm, the p38 MAPK pathway is an important regulator of protein turnover. For example, CFLAR is an inhibitor of TNF-induced apoptosis whose proteasome-mediated degradation is regulated by p38 MAPK phosphorylation. Ectodomain shedding of transmembrane proteins is regulated by p38 MAPKs as well. In response to inflammatory stimuli, p38 MAPKs phosphorylate the membrane-associated metalloprotease ADAM17. Such phosphorylation is required for ADAM17-mediated ectodomain shedding of TGF-alpha family ligands, which results in the activation of EGFR signaling and cell proliferation. Additional examples of p38 MAPK substrates are the FGFR1. FGFR1 can be translocated from the extracellular space into the cytosol and nucleus of target cells, and regulates processes such as rRNA synthesis and cell growth. FGFR1 translocation requires p38 MAPK activation. In the nucleus, many transcription factors are phosphorylated and activated by p38 MAPKs in response to different stimuli. Classical examples include ATF1, ATF2, ATF6, ELK1, PTPRH, DDIT3, TP53/p53 and MEF2C and MEF2A. The p38 MAPKs are emerging as important modulators of gene expression by regulating chromatin modifiers and remodelers. The promoters of several genes involved in the inflammatory response, such as IL6, IL8 and IL12B, display a p38 MAPK-dependent enrichment of histone H3 phosphorylation on 'Ser-10' (H3S10ph) in LPS-stimulated myeloid cells. This phosphorylation enhances the accessibility of the cryptic NF-kappa-B-binding sites marking promoters for increased NF-kappa-B recruitment. Phosphorylates NLRP1 downstream of MAP3K20/ZAK in response to UV-B irradiation and ribosome collisions, promoting activation of the NLRP1 inflammasome and pyroptosis.
TTD ID
T55729
Uniprot ID
Q15759
DrugMap ID
TT73U6C
Ensemble ID
ENST00000330651.11
HGNC ID
HGNC:6873
ChEMBL ID
CHEMBL3961

Target Site Mutations in Different Cell Lines

Cell line Mutation details Probe for labeling this protein in this cell
22RV1 Substitution: p.Q25P .
G415 SNV: p.G137R .
HCT116 Deletion: p.M265CfsTer6 .
HCT15 SNV: p.S293I .
JURKAT SNV: p.R136C .
MFE319 SNV: p.L285I .
NCIH1155 SNV: p.M265I .
NCIH358 SNV: p.P21T .
RKO SNV: p.C162R .
SUPT1 SNV: p.Y311H .
TOV21G SNV: p.A157D .

Probe(s) Labeling This Target

ABPP Probe
Click To Hide/Show 3 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
DBIA
 Probe Info 
C119(34.60)  LDD0209  [1]
IA-alkyne
 Probe Info 
N.A.  LDD0166  [2]
TFBX
 Probe Info 
N.A.  LDD0027  [3]

Competitor(s) Related to This Target

Competitor ID Name Cell line Binding Site(Ratio) Interaction ID Ref
 LDCM0284  AC24 HEK-293T C119(0.80)  LDD1523  [4]
 LDCM0293  AC32 HEK-293T C119(1.01)  LDD1532  [4]
 LDCM0302  AC40 HEK-293T C119(0.85)  LDD1541  [4]
 LDCM0310  AC48 HEK-293T C119(1.30)  LDD1549  [4]
 LDCM0319  AC56 HEK-293T C119(1.01)  LDD1558  [4]
 LDCM0328  AC64 HEK-293T C119(0.94)  LDD1567  [4]
 LDCM0345  AC8 HEK-293T C119(1.56)  LDD1569  [4]
 LDCM0275  AKOS034007705 HEK-293T C119(1.00)  LDD1514  [4]
 LDCM0390  CL12 HEK-293T C119(0.69)  LDD1594  [4]
 LDCM0412  CL24 HEK-293T C119(0.92)  LDD1616  [4]
 LDCM0425  CL36 HEK-293T C119(1.21)  LDD1629  [4]
 LDCM0438  CL48 HEK-293T C119(0.89)  LDD1642  [4]
 LDCM0452  CL60 HEK-293T C119(1.11)  LDD1655  [4]
 LDCM0465  CL72 HEK-293T C119(0.81)  LDD1668  [4]
 LDCM0478  CL84 HEK-293T C119(0.94)  LDD1681  [4]
 LDCM0491  CL96 HEK-293T C119(0.94)  LDD1694  [4]
 LDCM0023  KB03 Jurkat C119(34.60)  LDD0209  [1]

The Interaction Atlas With This Target

The Protein(s) Related To This Target

Enzyme
Click To Hide/Show 6 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Histone acetyltransferase KAT5 (KAT5) MYST (SAS/MOZ) family Q92993
Kallikrein-6 (KLK6) Peptidase S1 family Q92876
Protein kinase C alpha type (PRKCA) AGC Ser/Thr protein kinase family P17252
MAP kinase-activated protein kinase 3 (MAPKAPK3) CAMK Ser/Thr protein kinase family Q16644
Serine/threonine-protein kinase PAK 1 (PAK1) STE Ser/Thr protein kinase family Q13153
Fibroblast growth factor receptor 3 (FGFR3) Tyr protein kinase family P22607
Transporter and channel
Click To Hide/Show 3 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
14-3-3 protein gamma (YWHAG) 14-3-3 family P61981
Cellular tumor antigen p53 (TP53) P53 family P04637
Alpha-crystallin A chain (CRYAA) Small heat shock protein (HSP20) family P02489
Other
Click To Hide/Show 4 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Cytoplasmic dynein 1 heavy chain 1 (DYNC1H1) Dynein heavy chain family Q14204
Survival motor neuron protein (SMN1; SMN2) SMN family Q16637
Zinc finger HIT domain-containing protein 1 (ZNHIT1) ZNHIT1 family O43257
TAR DNA-binding protein 43 (TARDBP) . Q13148

The Drug(s) Related To This Target

Approved
Click To Hide/Show 2 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Minocycline Small molecular drug DB01017
Regorafenib Small molecular drug DB08896
Phase 2
Click To Hide/Show 1 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Vx-745 Small molecular drug D02NNV
Investigative
Click To Hide/Show 14 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
4,5,6,7-tetrabromo-1h-benzo[D][1,2,3]Triazole Small molecular drug D0O1YH
Bisindolylmaleimide-i Small molecular drug D0TO6S
Ci-1040 Small molecular drug D0B9BU
Kn-62 Small molecular drug D0N6ES
Kt-5720 Small molecular drug D0G2VC
L-779450 Small molecular drug D06WJA
Ml-3163 Small molecular drug D08DSJ
Ml-3375 Small molecular drug D09HBZ
Ml-3403 Small molecular drug D0W4FF
Ro-316233 Small molecular drug D0L8HO
Ro31-8220 Small molecular drug D0M5FF
Rwj-68354 Small molecular drug D06NUL
Kc706 . DB05157
Staurosporinone . D0GB4V
Discontinued
Click To Hide/Show 1 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Sb 235699 Small molecular drug D0W0AM

References

1 Covalent Inhibition by a Natural Product-Inspired Latent Electrophile. J Am Chem Soc. 2023 May 24;145(20):11097-11109. doi: 10.1021/jacs.3c00598. Epub 2023 May 15.
2 SP3-FAIMS Chemoproteomics for High-Coverage Profiling of the Human Cysteinome*. Chembiochem. 2021 May 14;22(10):1841-1851. doi: 10.1002/cbic.202000870. Epub 2021 Feb 18.
Mass spectrometry data entry: PXD023056 , PXD023059 , PXD023058 , PXD023057 , PXD023060
3 Chemoproteomic Profiling by Cysteine Fluoroalkylation Reveals Myrocin G as an Inhibitor of the Nonhomologous End Joining DNA Repair Pathway. J Am Chem Soc. 2021 Dec 8;143(48):20332-20342. doi: 10.1021/jacs.1c09724. Epub 2021 Nov 24.
Mass spectrometry data entry: PXD029255
4 Accelerating multiplexed profiling of protein-ligand interactions: High-throughput plate-based reactive cysteine profiling with minimal input. Cell Chem Biol. 2024 Mar 21;31(3):565-576.e4. doi: 10.1016/j.chembiol.2023.11.015. Epub 2023 Dec 19.
Mass spectrometry data entry: PXD044402